Literature DB >> 22925919

TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.

Peter B Jakus1, Nikoletta Kalman, Csenge Antus, Balazs Radnai, Zsuzsanna Tucsek, Ferenc Gallyas, Balazs Sumegi, Balazs Veres.   

Abstract

Resveratrol was suggested to inhibit Toll-like receptor (TLR)4-mediated activation of nuclear factor-κB (NF-κB) and Toll/interleukin-1 receptor domain-containing adaptor inducing interferon-β (TRIF)-(TANK)-binding kinase 1, but the myeloid differentiation primary response gene 88-tumor necrosis factor receptor-associated factor 6 (TRAF6) pathway is not involved in this effect. However, involvement of TRAF6 in this process is still elusive since cross talk between TRIF and TRAF6 has been reported in lipopolysaccharide (LPS)-induced signaling. Using RAW 264.7 macrophages, we determined the effect of resveratrol on LPS-induced TRAF6 expression, ubiquitination as well as activation of mitogen-activated protein (MAP) kinases and Akt in order to elucidate its involvement in TLR4 signaling. LPS-induced transient elevation in TRAF6 mRNA and protein expressions is suppressed by resveratrol. LPS induces the ubiquitination of TRAF6, which has been reported to be essential for Akt activation and for transforming growth factor-β activated kinase-1-NAP kinase kinase 6 (MKK6)-mediated p38 and c-Jun N-terminal kinase (JNK) activation. We found that resveratrol diminishes the effect of LPS on TRAF6 ubiquitination and activation of JNK and p38 MAP kinases, while it has no effect on the activation of extracellular-signal-regulated kinase (ERK)1/2. The effect of resveratrol on MAP kinase inhibition is significant since TRAF6 activation was reported to induce activation of JNK and p38 MAP kinase while not affecting ERK1/2. Moreover, Akt was identified previously as a direct target of TRAF6, and we found that, similarly to MAPKs, phosphorylation pattern of Akt followed the activation of TRAF6, and it was inhibited by resveratrol at all time points. Here, we provide the first evidence that resveratrol, by suppressing LPS-induced TRAF6 expression and ubiquitination, attenuates the LPS-induced TLR4-TRAF6, MAP kinase and Akt pathways that can be significant in its anti-inflammatory effects.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925919     DOI: 10.1016/j.jnutbio.2012.04.017

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  31 in total

1.  Lipoxin A4 inhibits lipopolysaccharide-induced production of inflammatory cytokines in keratinocytes by up-regulating SOCS2 and down-regulating TRAF6.

Authors:  Feng Hu; Ai-Ping Feng; Xin-Xin Liu; Song Zhang; Jun-Tao Xu; Xin Wang; Xue-Lian Zhong; Meng-Wen He; Hong-Xiang Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6.

Authors:  Sheng-Zhi Liu; Xue-Mei He; Xu Zhang; Fan-Cai Zeng; Fang Wang; Xiang-Yu Zhou
Journal:  Dig Dis Sci       Date:  2016-08-18       Impact factor: 3.199

3.  Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling.

Authors:  Lei Zhen; De-sheng Fan; Yan Zhang; Xin-ming Cao; Li-ming Wang
Journal:  Acta Pharmacol Sin       Date:  2014-12-22       Impact factor: 6.150

4.  Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation.

Authors:  Wol Soon Jo; Sung Dae Kim; Soo Kyung Jeong; Su Jung Oh; Moon Taek ParK; Chang Geun Lee; Young-Rok Kang; Min Ho Jeong
Journal:  Food Sci Biotechnol       Date:  2022-03-23       Impact factor: 2.391

Review 5.  Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury.

Authors:  Jason K Karimy; Benjamin C Reeves; Kristopher T Kahle
Journal:  Expert Opin Ther Targets       Date:  2020-04-17       Impact factor: 6.902

6.  Ablation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: role of Akt ubiquitination E3 ligase TRAF6.

Authors:  Yingmei Zhang; Xihui Xu; Asli F Ceylan-Isik; Maolong Dong; Zhaohui Pei; Yan Li; Jun Ren
Journal:  J Mol Cell Cardiol       Date:  2014-05-05       Impact factor: 5.000

7.  Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophages.

Authors:  Liang Chen; Sixing Yang; Elizabeth E Zumbrun; Hongbing Guan; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Mol Nutr Food Res       Date:  2015-03-18       Impact factor: 5.914

8.  Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-κB Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-κB Signaling through Cleavage of TANK.

Authors:  Li Huang; Qinfang Liu; Lijie Zhang; Quan Zhang; Liang Hu; Changyao Li; Shengnan Wang; Jiangnan Li; Yuanfeng Zhang; Huibin Yu; Yan Wang; Zhaohua Zhong; Tao Xiong; Xueshan Xia; Xiaojun Wang; Li Yu; Guohua Deng; Xuehui Cai; Shangjin Cui; Changjiang Weng
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

9.  TRAF6 Contributes to CFA-Induced Spinal Microglial Activation and Chronic Inflammatory Pain in Mice.

Authors:  Ying Lu; De-Li Cao; Ling-Jie Ma; Yong-Jing Gao
Journal:  Cell Mol Neurobiol       Date:  2021-03-10       Impact factor: 5.046

10.  Resveratrol-Loaded Lipid-Core Nanocapsules Modulate Acute Lung Inflammation and Oxidative Imbalance Induced by LPS in Mice.

Authors:  Maria Talita Pacheco de Oliveira; Diego de Sá Coutinho; Sílvia Stanisçuaski Guterres; Adriana Raffin Pohlmann; Patrícia Machado Rodrigues E Silva; Marco Aurélio Martins; Andressa Bernardi
Journal:  Pharmaceutics       Date:  2021-05-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.